PTGDR
MOLECULAR TARGETprostaglandin D2 receptor
PTGDR (prostaglandin D2 receptor) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PTGDR
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ramatroban | 2.64 | 13 |
| 2 | Prostaglandin D2 | 2.20 | 8 |
| 3 | mk 7246 | 1.95 | 6 |
| 4 | Dinoprost | 1.61 | 4 |
| 5 | Dinoprostone | 1.39 | 3 |
| 6 | Iloprost | 1.10 | 2 |
| 7 | Alprostadil | 0.69 | 1 |
| 8 | Cloprostenol | 0.69 | 1 |
About PTGDR as a Drug Target
PTGDR (prostaglandin D2 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented PTGDR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PTGDR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.